Compare Alcon AG (ALC) vs TKO Group Holdings Inc (TKO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alcon AG vs TKO Group Holdings Inc — how do they compare? Alcon AG trades at $74.32 (market cap $36.44B), while TKO Group Holdings Inc trades at $195.16 (market cap $14.24B). The key difference: Alcon AG is far larger — about 2.6× TKO Group Holdings Inc's market cap, and TKO Group Holdings Inc pays the higher dividend (1.6%). Which is the better fit depends on your goals.
| ALC | TKO | |
|---|---|---|
Market Cap | $36.44B | $14.24B |
Sector | Health | Technology |
52-Week High | $90.12 | $224.96 |
52-Week Low | $62.02 | $176.49 |
Enterprise Value | $40.28B | $18.60B |
Dividend Yield | 0.48% | 1.6% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $73.59, down slightly by 0.05% today, with a bullish technical signal from moving averages and a consensus analyst price target of $86.67 implying 17.8% upside. Recent Q2 2026 earnings beat estimates with EPS of $0.84 versus $0.77 expected, and the company raised its 2026 profitability outlook, driving positive investor sentiment. Revenue growth has been steady, reaching $10.40 billion in 2025, though net income margin dipped to 5.92%.
The outlook is positive given strong earnings beats, raised guidance, and bullish analyst ratings, but risks include elevated P/E of 57.52, high RSI levels suggesting overbought conditions, and margin pressures from rising costs. Institutional ownership trends and recent collaborations, like with RxSight, support growth, yet macroeconomic and competitive factors warrant caution.
TKO trades at $195.14, up 3.02% today, with a bullish technical outlook supported by moving averages and strong institutional sentiment. Recent Q2 2026 results showed revenue of $1.55 billion, an 18% YoY increase, though EPS of $1.34 missed expectations. The company raised full-year guidance, reflecting confidence in media rights and live events. Analyst consensus is strongly bullish with an average price target of $228.17, representing 17% upside from current levels.
TKO's growth trajectory is supported by expanding media deals and global events, but high valuation multiples (P/E 68.33) pose risks if execution falters. Key opportunities include continued revenue momentum from UFC and WWE, while risks involve earnings volatility and competitive pressures. The stock remains attractive for growth-oriented investors despite premium pricing.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About TKO Group Holdings Inc
TKO Group Holdings is a premium sports and entertainment company that serves as the parent entity for the Ultimate Fighting Championship (UFC) and World Wrestling Entertainment (WWE). Formed through a seismic merger orchestrated by Endeavor, TKO leverages a combined global fanbase of over 1 billion to drive massive revenue through media rights, global live events, and a unified sponsorship platform, effectively monopolizing the professional combat sports landscape.
Read more on TKO →
